Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 13, 2021

SELL
$17.81 - $27.48 $539,643 - $832,644
-30,300 Closed
0 $0
Q1 2021

May 14, 2021

SELL
$22.0 - $35.01 $61,270 - $97,502
-2,785 Reduced 8.42%
30,300 $844,000
Q4 2020

Feb 02, 2021

SELL
$20.81 - $30.55 $12,486 - $18,330
-600 Reduced 1.78%
33,085 $828,000
Q3 2020

Nov 05, 2020

BUY
$17.5 - $30.23 $589,487 - $1.02 Million
33,685 New
33,685 $1.02 Million

Others Institutions Holding ANNX

About Annexon, Inc.


  • Ticker ANNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,617,700
  • Market Cap $335M
  • Description
  • Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...
More about ANNX
Track This Portfolio

Track California Public Employees Retirement System Portfolio

Follow California Public Employees Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.